NCT00755794View on ClinicalTrials.gov

The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)

PHASE3CompletedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Asthma
Interventions
DRUG

montelukast sodium

Montelukast Tablet, 10 mg, 8 weeks, daily

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00755794 - The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384) | Biotech Hunter | Biotech Hunter